powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1609137595
Scott Barb
M.D.
Ophthalmology
Boston,
MA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
PRESCRIBING · PART D · 2024
Total Rx claims
300
Beneficiaries
—
Total drug cost
$11K
Distinct drugs
7
Brand share
24.0%
Top prescribed drugs
Prednisolone Acetate
111 claims
Ketorolac Tromethamine
89 claims
Neomycin/Polymyxin B/Dexametha
40 claims
Dorzolamide Hcl/Timolol Maleat
19 claims
Atropine Sulfate
16 claims
QUALITY · MIPS · 2024
Final MIPS score
90.6
Quality
86.7
Cost
0.0
Improvement activities
40.0
Promoting interop.
93.0
Payment adjustment
0.66%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$1K
Payment records
33
By payment type
Food and Beverage
$1K
Top paying entities
Food and Beverage
$1K
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
3,282
Unique beneficiaries
—
Total services
52,730
Distinct HCPCS
17
Medicare payment
$3.6M
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 558 Ophthalmology providers in MA — top quintile (cohort median 1,976).
